Procyrion has received Breakthrough Device designation by the US FDA for its Aortix system. According to a press release, Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalised for acute decompensated heart failure with worsening renal function. Through the Breakthrough Device designation programme, Procyrion can [...]